1. Home
  2. TBPH vs ASTL Comparison

TBPH vs ASTL Comparison

Compare TBPH & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • ASTL
  • Stock Information
  • Founded
  • TBPH 2013
  • ASTL 1902
  • Country
  • TBPH United States
  • ASTL Canada
  • Employees
  • TBPH N/A
  • ASTL N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • ASTL Steel/Iron Ore
  • Sector
  • TBPH Health Care
  • ASTL Industrials
  • Exchange
  • TBPH Nasdaq
  • ASTL Nasdaq
  • Market Cap
  • TBPH 464.5M
  • ASTL 532.0M
  • IPO Year
  • TBPH N/A
  • ASTL N/A
  • Fundamental
  • Price
  • TBPH $10.77
  • ASTL $5.30
  • Analyst Decision
  • TBPH Buy
  • ASTL
  • Analyst Count
  • TBPH 3
  • ASTL 0
  • Target Price
  • TBPH $11.33
  • ASTL N/A
  • AVG Volume (30 Days)
  • TBPH 379.4K
  • ASTL 798.9K
  • Earning Date
  • TBPH 05-08-2025
  • ASTL 06-20-2025
  • Dividend Yield
  • TBPH N/A
  • ASTL 3.78%
  • EPS Growth
  • TBPH N/A
  • ASTL N/A
  • EPS
  • TBPH N/A
  • ASTL N/A
  • Revenue
  • TBPH $65,266,000.00
  • ASTL $1,635,857,227.00
  • Revenue This Year
  • TBPH $51.09
  • ASTL $1.72
  • Revenue Next Year
  • TBPH N/A
  • ASTL $21.15
  • P/E Ratio
  • TBPH N/A
  • ASTL N/A
  • Revenue Growth
  • TBPH 6.11
  • ASTL N/A
  • 52 Week Low
  • TBPH $7.44
  • ASTL $4.17
  • 52 Week High
  • TBPH $11.82
  • ASTL $12.14
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 64.32
  • ASTL 47.00
  • Support Level
  • TBPH $9.10
  • ASTL $4.71
  • Resistance Level
  • TBPH $11.82
  • ASTL $5.63
  • Average True Range (ATR)
  • TBPH 0.39
  • ASTL 0.24
  • MACD
  • TBPH 0.19
  • ASTL -0.04
  • Stochastic Oscillator
  • TBPH 62.23
  • ASTL 52.21

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: